Last update:

Oncology & Cancer news

Oncology & Cancer

Chronic stress accelerates colorectal cancer progression by disrupting the balance of gut microbiota, study shows

Cutting-edge research has uncovered how chronic stress disrupts the balance of gut microbiota to speed up the progression of colorectal cancer (CRC), opening new avenues for CRC prevention and treatment.

Oncology & Cancer

Dense breasts can make it harder to spot cancer on a mammogram

When a woman has a mammogram, the most important finding is whether there's any sign of breast cancer.

Oncology & Cancer

An AI-powered pipeline for personalized cancer vaccines

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses ...

Oncology & Cancer

Long-term study shows early prostate cancer surgery extended life

The survival rate of men with prostate cancer who had their entire prostate gland removed immediately after the tumor was detected increased by 17 percentage points compared with those who did not have treatment until the ...

Oncology & Cancer

Study uncovers mutations and DNA structures driving bladder cancer

How bladder cancer originates and progresses has been illuminated as never before in a study led by researchers at Weill Cornell Medicine and the New York Genome Center. The researchers found that antiviral enzymes that mutate ...

Oncology & Cancer

Conversation tool to help cancer patients with treatment choices

Researchers at the Leiden Institute of Advanced Computer Science (LIACS) are collaborating on the development of a conversation tool for patients with breast, prostate and skin cancer. The aim is to create a conversation ...

Oncology & Cancer

Trends in genitourinary cancers examined in the United States

The highest incidence rates of bladder cancer are seen in the Northeast, while the West has the highest deaths rates for prostate cancer among non-Hispanic White men, according to a study published online Dec. 21 in European ...

Medications

Are the benefits of new cancer drugs worth the cost?

An international research group including scientists from Italy, the United States, Ireland, and Israel have published a three-year analysis of the Mesothelioma (Me) drug trial, Check-Mate 743 (CM-743). The trial studied ...

Oncology & Cancer

Rethinking how cancer cells evade targeted therapy

Glioblastomas (GBMs) are incurable brain tumors with a prognosis of about one-and-a half years on average. They are highly resistant to treatment and have defied all attempts at precision therapy.

Oncology & Cancer

Why don't T cells destroy solid tumors during immunotherapy?

The great hope of cancer immunotherapy is to bolster our own immune cells in specific ways to keep cancer cells from evading our immune system. Although much progress has been made, immunotherapy does not always work well. ...

Oncology & Cancer

Study identifies new therapeutic target for tumor treatment

Northwestern Medicine scientists have identified a new therapeutic target for tumors and developed a compound which slowed tumor growth and bolsters immune responses in mice, according to research published in Science Advances.